Access to Triptans for Acute Episodic Migraine: A Qualitative Study

Publisher： John Wiley & Sons Inc

E-ISSN： 1526-4610|55|S4|199-211

ISSN： 0017-8748

Source： HEADACHE, Vol.55, Iss.S4, 2015-07, pp. : 199-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triptans for Acute Migraine: A Drug Class Review

By  

HEADACHE, Vol. 55, Iss. 7, 2015-07 ,pp. : 921-922

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Treatment Optimization in Episodic and Chronic Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study

By  

HEADACHE, Vol. 55, Iss. 4, 2015-04 ,pp. : 502-518

John Wiley & Sons Inc

Access to resources Recommend Favorite

Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta‐Analysis

By  

HEADACHE, Vol. 55, Iss. S4, 2015-07 ,pp. : 221-235

John Wiley & Sons Inc

Access to resources Recommend Favorite

Triptans for Acute Migraine: Drug Class Review to Help Inform Policy Decisions

By  

HEADACHE, Vol. 55, Iss. S4, 2015-07 ,pp. : 191-198

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Experience of Combining Agents, Specially Triptans and Non Steroidal Anti-Inflammatory Drugs, for the Acute Treatment of Migraine - A Review

By  

Recent Patents on CNS Drug Discovery, Vol. 2, Iss. 2, 2007-01 ,pp. : 141-144

Bentham Science Publishers

Access to resources Recommend Favorite